Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. Ghilezan

Outcomes and Toxicity From a Prospective Study of Moderate Hypofractionated Radiation Therapy for Prostate Cancer

International Journal of Radiation Oncology Biology Physics

English

Highly Favorable Preliminary Clinical and Toxicity Outcomes for Low- And Intermediate-Risk Prostate Cancer Patients Treated With High-Dose-Rate Brachytherapy in a Single Fraction of 19 Gy

International Journal of Radiation Oncology Biology Physics

English

Related publications

Outcomes and Toxicity From a Prospective Study of Moderately Hypofractionated Radiotherapy for Prostate Cancer

Advances in Radiation Oncology

English

Five-Year Outcomes From a Prospective Trial of Image Guided Accelerated Hypofractionated Proton Therapy for Prostate Cancer

International Journal of Radiation Oncology Biology Physics

English

5-Day Hypofractionated Preoperative Radiation Therapy in Soft Tissue Sarcoma: Preliminary Toxicity and Pathologic Outcomes From a Prospective Phase 2 Study

International Journal of Radiation Oncology Biology Physics

English

Long-Term Toxicity and Outcomes of Hypofractionated Radiation Therapy With an Incorporated Boost for Early-Stage Breast Cancer

International Journal of Radiation Oncology Biology Physics

English

Hypofractionated Stereotactic Body Radiation Therapy as Monotherapy for Intermediate-Risk Prostate Cancer

English

Intermediate Risk Prostate Cancer Patients Treated With Image Guided Hypofractionated Radiation Therapy

International Journal of Radiation Oncology Biology Physics

English

Toxicity and Biochemical Outcomes of Dose-Intensified Post-Operative Radiation Therapy for Prostate Cancer: Results of a Randomized Phase III Trial

International Journal of Radiation Oncology Biology Physics

English

Hypofractionated Stereotactic Radiation Therapy for Advanced Non-Small Cell Lung Cancer: Report on Clinical Outcome and Toxicity

International Journal of Radiation Oncology Biology Physics

English

Ultra-Hypofractionated Radiation Therapy for Unfavorable Intermediate-Risk and High-Risk Prostate Cancer Is Safe and Effective: 5-Year Outcomes of a Phase II Trial

BJU International

Urology

2019

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. Ghilezan

Outcomes and Toxicity From a Prospective Study of Moderate Hypofractionated Radiation Therapy for Prostate Cancer

Highly Favorable Preliminary Clinical and Toxicity Outcomes for Low- And Intermediate-Risk Prostate Cancer Patients Treated With High-Dose-Rate Brachytherapy in a Single Fraction of 19 Gy

Related publications

Outcomes and Toxicity From a Prospective Study of Moderately Hypofractionated Radiotherapy for Prostate Cancer

Five-Year Outcomes From a Prospective Trial of Image Guided Accelerated Hypofractionated Proton Therapy for Prostate Cancer

5-Day Hypofractionated Preoperative Radiation Therapy in Soft Tissue Sarcoma: Preliminary Toxicity and Pathologic Outcomes From a Prospective Phase 2 Study

Long-Term Toxicity and Outcomes of Hypofractionated Radiation Therapy With an Incorporated Boost for Early-Stage Breast Cancer

Hypofractionated Stereotactic Body Radiation Therapy as Monotherapy for Intermediate-Risk Prostate Cancer

Intermediate Risk Prostate Cancer Patients Treated With Image Guided Hypofractionated Radiation Therapy

Toxicity and Biochemical Outcomes of Dose-Intensified Post-Operative Radiation Therapy for Prostate Cancer: Results of a Randomized Phase III Trial

Hypofractionated Stereotactic Radiation Therapy for Advanced Non-Small Cell Lung Cancer: Report on Clinical Outcome and Toxicity

Ultra-Hypofractionated Radiation Therapy for Unfavorable Intermediate-Risk and High-Risk Prostate Cancer Is Safe and Effective: 5-Year Outcomes of a Phase II Trial